• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

RepVue

Trophies

  1. 1

    First Message

    Post a message somewhere on the site to receive this.
Top Bottom
Back